- Home
- AGEN vs VFF Comparison
AGEN vs VFF Comparison
Compare AGEN & VFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- VFF
- Stock Information
- Founded
- AGEN 1994
- VFF 1989
- Country
- AGEN United States
- VFF United States
- Employees
- AGEN N/A
- VFF N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- VFF
- Sector
- AGEN Health Care
- VFF
- Exchange
- AGEN Nasdaq
- VFF Nasdaq
- Market Cap
- AGEN 87.7M
- VFF 79.3M
- IPO Year
- AGEN 2000
- VFF N/A
- Fundamental
- Price
- AGEN $5.16
- VFF $1.13
- Analyst Decision
- AGEN Buy
- VFF Buy
- Analyst Count
- AGEN 4
- VFF 1
- Target Price
- AGEN $13.00
- VFF N/A
- AVG Volume (30 Days)
- AGEN 1.6M
- VFF 1.4M
- Earning Date
- AGEN 08-07-2025
- VFF 08-07-2025
- Dividend Yield
- AGEN N/A
- VFF N/A
- EPS Growth
- AGEN N/A
- VFF N/A
- EPS
- AGEN N/A
- VFF N/A
- Revenue
- AGEN $99,524,000.00
- VFF $335,178,000.00
- Revenue This Year
- AGEN $14.49
- VFF N/A
- Revenue Next Year
- AGEN N/A
- VFF N/A
- P/E Ratio
- AGEN N/A
- VFF N/A
- Revenue Growth
- AGEN N/A
- VFF 12.09
- 52 Week Low
- AGEN $1.38
- VFF $0.45
- 52 Week High
- AGEN $18.74
- VFF $1.32
- Technical
- Relative Strength Index (RSI)
- AGEN 62.39
- VFF 57.87
- Support Level
- AGEN $5.06
- VFF $1.18
- Resistance Level
- AGEN $6.35
- VFF $1.28
- Average True Range (ATR)
- AGEN 0.59
- VFF 0.09
- MACD
- AGEN 0.12
- VFF -0.02
- Stochastic Oscillator
- AGEN 65.00
- VFF 17.39
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About VFF Village Farms International Inc.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.